Sarepta Therapeutics, Inc. SRPT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s enterprise value?
- Sarepta Therapeutics, Inc. (SRPT) reported enterprise value of $2.02B in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s enterprise value changed year-over-year?
- Sarepta Therapeutics, Inc.'s enterprise value decreased by 67.2% year-over-year, from $6.16B to $2.02B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s enterprise value has grown at a -32.8% compound annual growth rate (CAGR), from $12.14B to $1.66B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.